Kosan's drug is in midstage clinical trials, and it may have an oral version in testing by year-end.

FORBES: Magazine Article

Rather than testing Xarelto against warfarin, the current standard in oral anti-coagulants, Xarelto was studied against placebo.

FORBES: Why Xarelto for ACS was doomed to fail